[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

US11066411B2 · kind B2 · utility

Assignee

• Medshine Discovery Inc. · CN

Inventors

• Kevin X. Chen · Edison, US
• Yanxin YU · Shanghai, CN
• Xinde Chen · Shanghai, CN
• Li Zhang · New Milford, US
• Zhaoguo Chen · Shanghai, CN
• Cheng Xie · Shanghai, CN
• Xiaofei Wang · Shanghai, CN
• Linghui Wu · Shanghai, CN
• Guoping HU · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Apr 8, 2018
• Grant date: Jul 20, 2021
• Expiry date: Apr 8, 2038

Classification

• Technology area (CPC —): General

Abstract

Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.